

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glomerular visceral epithelial cell development (GO:0072015) | 6.37350157 |
| 2 | glomerular epithelial cell development (GO:0072310) | 5.54616057 |
| 3 | germinal center formation (GO:0002467) | 5.08570731 |
| 4 | glomerular basement membrane development (GO:0032836) | 4.22173838 |
| 5 | regulation of germinal center formation (GO:0002634) | 3.89733192 |
| 6 | semaphorin-plexin signaling pathway (GO:0071526) | 3.78716886 |
| 7 | mannose metabolic process (GO:0006013) | 3.69489137 |
| 8 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.54488637 |
| 9 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.54488637 |
| 10 | plasma membrane repair (GO:0001778) | 3.47661580 |
| 11 | negative regulation of Rho protein signal transduction (GO:0035024) | 3.45255687 |
| 12 | mitochondrion distribution (GO:0048311) | 3.36916902 |
| 13 | endothelial cell chemotaxis (GO:0035767) | 3.34852031 |
| 14 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.31624500 |
| 15 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 3.28275082 |
| 16 | cell-substrate junction assembly (GO:0007044) | 3.21650320 |
| 17 | regulation of ARF GTPase activity (GO:0032312) | 3.20977169 |
| 18 | response to muramyl dipeptide (GO:0032495) | 3.18895903 |
| 19 | post-embryonic morphogenesis (GO:0009886) | 3.15203917 |
| 20 | positive regulation of p38MAPK cascade (GO:1900745) | 3.09402241 |
| 21 | regulation of platelet aggregation (GO:0090330) | 3.07848315 |
| 22 | cell adhesion mediated by integrin (GO:0033627) | 3.04475339 |
| 23 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.04196892 |
| 24 | protein localization to endosome (GO:0036010) | 3.03205917 |
| 25 | regulation of memory T cell differentiation (GO:0043380) | 2.98281096 |
| 26 | positive regulation of receptor recycling (GO:0001921) | 2.98081482 |
| 27 | G-protein coupled receptor internalization (GO:0002031) | 2.98044099 |
| 28 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.95480999 |
| 29 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.94548815 |
| 30 | membrane depolarization during action potential (GO:0086010) | 2.94281178 |
| 31 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.93183371 |
| 32 | negative regulation of B cell mediated immunity (GO:0002713) | 2.93183371 |
| 33 | activation of Rac GTPase activity (GO:0032863) | 2.87832535 |
| 34 | epithelial cell differentiation involved in kidney development (GO:0035850) | 2.85358158 |
| 35 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.83565075 |
| 36 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.82561469 |
| 37 | negative regulation of fatty acid transport (GO:2000192) | 2.82287962 |
| 38 | hemidesmosome assembly (GO:0031581) | 2.78175964 |
| 39 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.76618636 |
| 40 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.76471156 |
| 41 | positive regulation of protein kinase C signaling (GO:0090037) | 2.76134579 |
| 42 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.74300455 |
| 43 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.74279900 |
| 44 | carnitine shuttle (GO:0006853) | 2.73215002 |
| 45 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.71013153 |
| 46 | modulation by symbiont of host immune response (GO:0052553) | 2.71013153 |
| 47 | positive regulation by symbiont of host defense response (GO:0052509) | 2.71013153 |
| 48 | modulation by symbiont of host defense response (GO:0052031) | 2.71013153 |
| 49 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.71013153 |
| 50 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.71013153 |
| 51 | phospholipid scrambling (GO:0017121) | 2.70324457 |
| 52 | desmosome organization (GO:0002934) | 2.70312655 |
| 53 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.66057654 |
| 54 | cell volume homeostasis (GO:0006884) | 2.62808508 |
| 55 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.60065538 |
| 56 | I-kappaB phosphorylation (GO:0007252) | 2.58929649 |
| 57 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.57139723 |
| 58 | signal complex assembly (GO:0007172) | 2.56800432 |
| 59 | activation of MAPKKK activity (GO:0000185) | 2.56666029 |
| 60 | regulation of p38MAPK cascade (GO:1900744) | 2.56285834 |
| 61 | negative regulation of granulocyte differentiation (GO:0030853) | 2.56169928 |
| 62 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.53937211 |
| 63 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.51815236 |
| 64 | endothelium development (GO:0003158) | 2.51587758 |
| 65 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.49824443 |
| 66 | activation of JUN kinase activity (GO:0007257) | 2.48761209 |
| 67 | positive regulation of fibroblast migration (GO:0010763) | 2.48687651 |
| 68 | negative regulation of type 2 immune response (GO:0002829) | 2.48161143 |
| 69 | response to laminar fluid shear stress (GO:0034616) | 2.47185569 |
| 70 | modulation by symbiont of host cellular process (GO:0044068) | 2.47145427 |
| 71 | apoptotic process involved in morphogenesis (GO:0060561) | 2.46102393 |
| 72 | adherens junction assembly (GO:0034333) | 2.45856745 |
| 73 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.45645715 |
| 74 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.45152297 |
| 75 | endocytic recycling (GO:0032456) | 2.44363964 |
| 76 | atrioventricular valve morphogenesis (GO:0003181) | 2.43416295 |
| 77 | neurofilament cytoskeleton organization (GO:0060052) | 2.42684467 |
| 78 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.41604628 |
| 79 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.39961385 |
| 80 | NIK/NF-kappaB signaling (GO:0038061) | 2.38640809 |
| 81 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.37222353 |
| 82 | cardiac conduction (GO:0061337) | 2.37048722 |
| 83 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.36278942 |
| 84 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.36194486 |
| 85 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.36112888 |
| 86 | positive regulation of histone deacetylation (GO:0031065) | 2.35996370 |
| 87 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.34338828 |
| 88 | acrosome reaction (GO:0007340) | 2.34193619 |
| 89 | intermediate filament organization (GO:0045109) | 2.34095437 |
| 90 | macrophage activation involved in immune response (GO:0002281) | 2.33581622 |
| 91 | response to type I interferon (GO:0034340) | 2.31588777 |
| 92 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.31188512 |
| 93 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.28850260 |
| 94 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.28319182 |
| 95 | positive regulation of Rac GTPase activity (GO:0032855) | 2.28197990 |
| 96 | adenosine receptor signaling pathway (GO:0001973) | 2.27915261 |
| 97 | regulation of alkaline phosphatase activity (GO:0010692) | 2.27373175 |
| 98 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.27369657 |
| 99 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.27365462 |
| 100 | response to manganese ion (GO:0010042) | 2.27350178 |
| 101 | growth hormone receptor signaling pathway (GO:0060396) | 2.26333427 |
| 102 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.25999567 |
| 103 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.25727861 |
| 104 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.25282877 |
| 105 | response to peptidoglycan (GO:0032494) | 2.24353140 |
| 106 | negative regulation of interleukin-12 production (GO:0032695) | 2.24190299 |
| 107 | regulation of ARF protein signal transduction (GO:0032012) | 2.24126266 |
| 108 | carnitine transmembrane transport (GO:1902603) | 2.23821708 |
| 109 | basement membrane organization (GO:0071711) | 2.23248256 |
| 110 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.22803319 |
| 111 | positive regulation of muscle hypertrophy (GO:0014742) | 2.22803319 |
| 112 | type I interferon signaling pathway (GO:0060337) | 2.22638000 |
| 113 | cellular response to type I interferon (GO:0071357) | 2.22638000 |
| 114 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.22051988 |
| 115 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.21394986 |
| 116 | negative regulation of cell killing (GO:0031342) | 2.21009538 |
| 117 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.21009538 |
| 118 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.20704866 |
| 119 | cell-substrate adherens junction assembly (GO:0007045) | 2.19901841 |
| 120 | focal adhesion assembly (GO:0048041) | 2.19901841 |
| 121 | response to fluid shear stress (GO:0034405) | 2.19749878 |
| 122 | establishment of skin barrier (GO:0061436) | 2.19068437 |
| 123 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 2.18652840 |
| 124 | regulation of water loss via skin (GO:0033561) | 2.18173965 |
| 125 | embryonic viscerocranium morphogenesis (GO:0048703) | 2.17055214 |
| 126 | fatty acid transmembrane transport (GO:1902001) | 2.16512512 |
| 127 | cAMP biosynthetic process (GO:0006171) | 2.16084552 |
| 128 | apoptotic cell clearance (GO:0043277) | 2.15630842 |
| 129 | thymic T cell selection (GO:0045061) | 2.15553237 |
| 130 | positive regulation of Rap GTPase activity (GO:0032854) | 2.14497312 |
| 131 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.13745404 |
| 132 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.13531381 |
| 133 | Rho protein signal transduction (GO:0007266) | 2.13380191 |
| 134 | protein kinase C signaling (GO:0070528) | 2.13012812 |
| 135 | positive regulation of protein dephosphorylation (GO:0035307) | 2.12725220 |
| 136 | angiogenesis involved in wound healing (GO:0060055) | 2.12105310 |
| 137 | cellular response to virus (GO:0098586) | 2.11853859 |
| 138 | axon extension involved in axon guidance (GO:0048846) | 2.11803399 |
| 139 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.11803399 |
| 140 | neuronal action potential propagation (GO:0019227) | 2.11793592 |
| 141 | positive regulation of type 2 immune response (GO:0002830) | 2.10320782 |
| 142 | positive regulation of odontogenesis (GO:0042482) | 2.09310602 |
| 143 | negative regulation of Ras protein signal transduction (GO:0046580) | 2.08504922 |
| 144 | positive regulation of heat generation (GO:0031652) | 2.08170862 |
| 145 | detection of other organism (GO:0098543) | 2.07939821 |
| 146 | wound healing, spreading of epidermal cells (GO:0035313) | 2.07731741 |
| 147 | endodermal cell differentiation (GO:0035987) | 2.07275843 |
| 148 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.06621419 |
| 149 | coronary vasculature morphogenesis (GO:0060977) | 2.06570436 |
| 150 | negative regulation of myotube differentiation (GO:0010832) | 2.06255841 |
| 151 | cellular response to ethanol (GO:0071361) | 2.06203085 |
| 152 | cell communication involved in cardiac conduction (GO:0086065) | 2.06095674 |
| 153 | barbed-end actin filament capping (GO:0051016) | 2.05915743 |
| 154 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.05747654 |
| 155 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.05728458 |
| 156 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.04938798 |
| 157 | positive regulation of cholesterol efflux (GO:0010875) | 2.04715509 |
| 158 | positive regulation of Rho GTPase activity (GO:0032321) | 2.04708868 |
| 159 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.04176328 |
| 160 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.04045793 |
| 161 | muscle atrophy (GO:0014889) | 2.03999698 |
| 162 | oxygen transport (GO:0015671) | 2.03797866 |
| 163 | regulation of Cdc42 GTPase activity (GO:0043088) | 2.03794194 |
| 164 | regulation of integrin activation (GO:0033623) | 2.03490962 |
| 165 | negative regulation of small GTPase mediated signal transduction (GO:0051058) | 2.02644848 |
| 166 | microglial cell activation (GO:0001774) | 2.02633060 |
| 167 | vesicle transport along microtubule (GO:0047496) | 2.02275010 |
| 168 | amino-acid betaine transport (GO:0015838) | 2.01979802 |
| 169 | carnitine transport (GO:0015879) | 2.01979802 |
| 170 | righting reflex (GO:0060013) | 2.01827203 |
| 171 | regulation of ruffle assembly (GO:1900027) | 2.01703663 |
| 172 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.01678924 |
| 173 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.01678924 |
| 174 | nerve growth factor signaling pathway (GO:0038180) | 2.01669131 |
| 175 | substrate-dependent cell migration (GO:0006929) | 2.01274345 |
| 176 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.01128385 |
| 177 | regulation of Rap GTPase activity (GO:0032317) | 2.00727040 |
| 178 | cell-cell junction maintenance (GO:0045217) | 2.00513108 |
| 179 | histone H3-K4 trimethylation (GO:0080182) | 2.00329376 |
| 180 | negative regulation of viral release from host cell (GO:1902187) | 1.99967235 |
| 181 | synaptic vesicle endocytosis (GO:0048488) | 1.99913498 |
| 182 | skeletal muscle adaptation (GO:0043501) | 1.99809506 |
| 183 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 1.98709614 |
| 184 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 1.97568618 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.75117282 |
| 2 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.61098799 |
| 3 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.45578973 |
| 4 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.42753857 |
| 5 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.31739369 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.20017207 |
| 7 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.12780780 |
| 8 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.12566904 |
| 9 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.09766200 |
| 10 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.02224119 |
| 11 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.00077131 |
| 12 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.88154663 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.87360780 |
| 14 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.81325674 |
| 15 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.78915731 |
| 16 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.78214187 |
| 17 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.73237681 |
| 18 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.72974608 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.71443527 |
| 20 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.62379367 |
| 21 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.61618650 |
| 22 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.57733226 |
| 23 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.56934135 |
| 24 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.56802149 |
| 25 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.56232142 |
| 26 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.55344840 |
| 27 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.54838053 |
| 28 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.54704616 |
| 29 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.54301661 |
| 30 | TP53_16413492_ChIP-PET_HCT116_Human | 1.53975356 |
| 31 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.53473545 |
| 32 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.51582692 |
| 33 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.50398712 |
| 34 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.50165127 |
| 35 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.50024490 |
| 36 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.49982199 |
| 37 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.49363614 |
| 38 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.49035939 |
| 39 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.48878171 |
| 40 | P68_20966046_ChIP-Seq_HELA_Human | 1.48054586 |
| 41 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.47681858 |
| 42 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.47059572 |
| 43 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.46857711 |
| 44 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.44490282 |
| 45 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.44345594 |
| 46 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.43984355 |
| 47 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.43272258 |
| 48 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.42533484 |
| 49 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.42474477 |
| 50 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.40123949 |
| 51 | MYC_22102868_ChIP-Seq_BL_Human | 1.39755908 |
| 52 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.37559283 |
| 53 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.37559283 |
| 54 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.36205357 |
| 55 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.35449486 |
| 56 | KDM2B_26808549_Chip-Seq_K562_Human | 1.35145673 |
| 57 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.34471266 |
| 58 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.34299702 |
| 59 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.34263549 |
| 60 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.33374331 |
| 61 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.32726893 |
| 62 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.32022790 |
| 63 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.31607641 |
| 64 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.31383072 |
| 65 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.31271380 |
| 66 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.31105559 |
| 67 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.29966478 |
| 68 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.29742070 |
| 69 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.28862364 |
| 70 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.28690400 |
| 71 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.28461097 |
| 72 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.28421976 |
| 73 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.28052343 |
| 74 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.27842653 |
| 75 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26823336 |
| 76 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.26233915 |
| 77 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.25454461 |
| 78 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.24938676 |
| 79 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.24909073 |
| 80 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.24081551 |
| 81 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.24013434 |
| 82 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.23372341 |
| 83 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.23309990 |
| 84 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.22906451 |
| 85 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.22862614 |
| 86 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.22348157 |
| 87 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.22014910 |
| 88 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.21956831 |
| 89 | MAF_26560356_Chip-Seq_TH1_Human | 1.21668010 |
| 90 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21068679 |
| 91 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.20389087 |
| 92 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.18894555 |
| 93 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.18798455 |
| 94 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.18725654 |
| 95 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.18714063 |
| 96 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.17648220 |
| 97 | SPI1_23127762_ChIP-Seq_K562_Human | 1.17242828 |
| 98 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.16759225 |
| 99 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.16521832 |
| 100 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16460196 |
| 101 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.15814533 |
| 102 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.15691691 |
| 103 | MAF_26560356_Chip-Seq_TH2_Human | 1.15152201 |
| 104 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.14088590 |
| 105 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.13958344 |
| 106 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.13821707 |
| 107 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.13777210 |
| 108 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.13143388 |
| 109 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.13001354 |
| 110 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.12915225 |
| 111 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.12570619 |
| 112 | STAT3_23295773_ChIP-Seq_U87_Human | 1.12364633 |
| 113 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.12228298 |
| 114 | RXR_22108803_ChIP-Seq_LS180_Human | 1.10009917 |
| 115 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09573171 |
| 116 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.08302366 |
| 117 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.07981224 |
| 118 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.06612301 |
| 119 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.06190117 |
| 120 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.05799215 |
| 121 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.05745175 |
| 122 | UTX_26944678_Chip-Seq_JUKART_Human | 1.04240594 |
| 123 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.03713372 |
| 124 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.03158487 |
| 125 | GATA1_19941826_ChIP-Seq_K562_Human | 1.03136441 |
| 126 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.02129271 |
| 127 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.01736466 |
| 128 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.01478409 |
| 129 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.01212378 |
| 130 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.01202086 |
| 131 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.01066393 |
| 132 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.01059216 |
| 133 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.00918952 |
| 134 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.00816677 |
| 135 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.00572790 |
| 136 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.98525196 |
| 137 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.97965530 |
| 138 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.97371825 |
| 139 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.97371825 |
| 140 | TCF4_23295773_ChIP-Seq_U87_Human | 0.97302656 |
| 141 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.96724478 |
| 142 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.96671792 |
| 143 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.96663276 |
| 144 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.96504437 |
| 145 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.96249981 |
| 146 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.96130617 |
| 147 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.95454901 |
| 148 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.95294821 |
| 149 | AR_19668381_ChIP-Seq_PC3_Human | 0.94796235 |
| 150 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.93824225 |
| 151 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93537777 |
| 152 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.93319104 |
| 153 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.92884694 |
| 154 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92818624 |
| 155 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.91990393 |
| 156 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.91579893 |
| 157 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.91552364 |
| 158 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.90977980 |
| 159 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.90830542 |
| 160 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90394148 |
| 161 | ATF3_27146783_Chip-Seq_COLON_Human | 0.90269789 |
| 162 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.90233561 |
| 163 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.89998655 |
| 164 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.89799792 |
| 165 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.89799792 |
| 166 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.89521952 |
| 167 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.89104214 |
| 168 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.88666331 |
| 169 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.88507432 |
| 170 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.87427290 |
| 171 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.86643953 |
| 172 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.85683051 |
| 173 | TBL1_22424771_ChIP-Seq_293T_Human | 0.84470415 |
| 174 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.84141348 |
| 175 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.83105656 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 4.77962445 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 3.61784148 |
| 3 | MP0005623_abnormal_meninges_morphology | 3.53950738 |
| 4 | MP0001968_abnormal_touch/_nociception | 3.46316024 |
| 5 | MP0000751_myopathy | 3.40866408 |
| 6 | MP0002736_abnormal_nociception_after | 2.91958259 |
| 7 | MP0003045_fibrosis | 2.90461452 |
| 8 | MP0002735_abnormal_chemical_nociception | 2.88465365 |
| 9 | MP0004510_myositis | 2.88253367 |
| 10 | MP0000579_abnormal_nail_morphology | 2.67706574 |
| 11 | MP0004859_abnormal_synaptic_plasticity | 2.65386600 |
| 12 | MP0003453_abnormal_keratinocyte_physiol | 2.45610917 |
| 13 | MP0001849_ear_inflammation | 2.33436148 |
| 14 | MP0005409_darkened_coat_color | 2.25280389 |
| 15 | MP0000749_muscle_degeneration | 2.23351125 |
| 16 | MP0003436_decreased_susceptibility_to | 2.23150000 |
| 17 | MP0010368_abnormal_lymphatic_system | 2.19402239 |
| 18 | MP0005451_abnormal_body_composition | 2.17197651 |
| 19 | MP0004130_abnormal_muscle_cell | 2.13299895 |
| 20 | MP0003279_aneurysm | 2.11592806 |
| 21 | MP0003303_peritoneal_inflammation | 2.06367917 |
| 22 | MP0009046_muscle_twitch | 2.04764952 |
| 23 | MP0000747_muscle_weakness | 2.04120822 |
| 24 | MP0004381_abnormal_hair_follicle | 2.02079870 |
| 25 | MP0009840_abnormal_foam_cell | 1.98907499 |
| 26 | MP0003724_increased_susceptibility_to | 1.98223818 |
| 27 | MP0003183_abnormal_peptide_metabolism | 1.90714821 |
| 28 | MP0005670_abnormal_white_adipose | 1.90509850 |
| 29 | MP0004270_analgesia | 1.87551188 |
| 30 | MP0003091_abnormal_cell_migration | 1.85619587 |
| 31 | MP0004858_abnormal_nervous_system | 1.84988446 |
| 32 | MP0002933_joint_inflammation | 1.82316301 |
| 33 | MP0002796_impaired_skin_barrier | 1.80338789 |
| 34 | MP0003787_abnormal_imprinting | 1.80325880 |
| 35 | MP0006082_CNS_inflammation | 1.73144727 |
| 36 | MP0008004_abnormal_stomach_pH | 1.68041938 |
| 37 | MP0003566_abnormal_cell_adhesion | 1.68016362 |
| 38 | MP0005167_abnormal_blood-brain_barrier | 1.67139833 |
| 39 | MP0003191_abnormal_cellular_cholesterol | 1.66677099 |
| 40 | MP0004145_abnormal_muscle_electrophysio | 1.65195469 |
| 41 | MP0008961_abnormal_basal_metabolism | 1.64345451 |
| 42 | MP0002733_abnormal_thermal_nociception | 1.64002459 |
| 43 | MP0009278_abnormal_bone_marrow | 1.61473838 |
| 44 | MP0002234_abnormal_pharynx_morphology | 1.60010394 |
| 45 | MP0002067_abnormal_sensory_capabilities | 1.58776499 |
| 46 | MP0002734_abnormal_mechanical_nocicepti | 1.54946098 |
| 47 | MP0003172_abnormal_lysosome_physiology | 1.54329894 |
| 48 | MP0003300_gastrointestinal_ulcer | 1.53431631 |
| 49 | MP0003635_abnormal_synaptic_transmissio | 1.51665193 |
| 50 | MP0000383_abnormal_hair_follicle | 1.50433402 |
| 51 | MP0005023_abnormal_wound_healing | 1.48006722 |
| 52 | MP0001348_abnormal_lacrimal_gland | 1.46900507 |
| 53 | MP0004185_abnormal_adipocyte_glucose | 1.46016956 |
| 54 | MP0010678_abnormal_skin_adnexa | 1.34683231 |
| 55 | MP0005275_abnormal_skin_tensile | 1.34544844 |
| 56 | MP0005000_abnormal_immune_tolerance | 1.34530950 |
| 57 | MP0002419_abnormal_innate_immunity | 1.32566541 |
| 58 | MP0005025_abnormal_response_to | 1.30936649 |
| 59 | MP0004084_abnormal_cardiac_muscle | 1.30299843 |
| 60 | MP0002998_abnormal_bone_remodeling | 1.30252949 |
| 61 | MP0001790_abnormal_immune_system | 1.28732996 |
| 62 | MP0005387_immune_system_phenotype | 1.28732996 |
| 63 | MP0002060_abnormal_skin_morphology | 1.28200273 |
| 64 | MP0008260_abnormal_autophagy | 1.27390700 |
| 65 | MP0002168_other_aberrant_phenotype | 1.26964745 |
| 66 | MP0000759_abnormal_skeletal_muscle | 1.26638912 |
| 67 | MP0002148_abnormal_hypersensitivity_rea | 1.25619949 |
| 68 | MP0001970_abnormal_pain_threshold | 1.25600650 |
| 69 | MP0003828_pulmonary_edema | 1.25220333 |
| 70 | MP0004087_abnormal_muscle_fiber | 1.24071794 |
| 71 | MP0010155_abnormal_intestine_physiology | 1.22726382 |
| 72 | MP0001533_abnormal_skeleton_physiology | 1.21605202 |
| 73 | MP0002106_abnormal_muscle_physiology | 1.20795466 |
| 74 | MP0006138_congestive_heart_failure | 1.19403308 |
| 75 | MP0003075_altered_response_to | 1.18712969 |
| 76 | MP0005410_abnormal_fertilization | 1.18422516 |
| 77 | MP0002064_seizures | 1.17488624 |
| 78 | MP0000465_gastrointestinal_hemorrhage | 1.16430777 |
| 79 | MP0002089_abnormal_postnatal_growth/wei | 1.15759339 |
| 80 | MP0004036_abnormal_muscle_relaxation | 1.15524359 |
| 81 | MP0002269_muscular_atrophy | 1.15186205 |
| 82 | MP0001486_abnormal_startle_reflex | 1.14331163 |
| 83 | MP0001216_abnormal_epidermal_layer | 1.12893026 |
| 84 | MP0000858_altered_metastatic_potential | 1.11612236 |
| 85 | MP0001853_heart_inflammation | 1.09625612 |
| 86 | MP0003763_abnormal_thymus_physiology | 1.09597397 |
| 87 | MP0009745_abnormal_behavioral_response | 1.08741790 |
| 88 | MP0009785_altered_susceptibility_to | 1.08350602 |
| 89 | MP0005310_abnormal_salivary_gland | 1.07333859 |
| 90 | MP0005058_abnormal_lysosome_morphology | 1.06206179 |
| 91 | MP0000750_abnormal_muscle_regeneration | 1.06116362 |
| 92 | MP0002452_abnormal_antigen_presenting | 1.04841385 |
| 93 | MP0001440_abnormal_grooming_behavior | 1.04353918 |
| 94 | MP0005595_abnormal_vascular_smooth | 1.04158028 |
| 95 | MP0005166_decreased_susceptibility_to | 1.03115626 |
| 96 | MP0002138_abnormal_hepatobiliary_system | 1.02873989 |
| 97 | MP0001800_abnormal_humoral_immune | 1.01764835 |
| 98 | MP0005666_abnormal_adipose_tissue | 1.00583300 |
| 99 | MP0001958_emphysema | 1.00209281 |
| 100 | MP0002723_abnormal_immune_serum | 1.00136791 |
| 101 | MP0002063_abnormal_learning/memory/cond | 0.99788322 |
| 102 | MP0005369_muscle_phenotype | 0.99021973 |
| 103 | MP0003646_muscle_fatigue | 0.98999217 |
| 104 | MP0002332_abnormal_exercise_endurance | 0.98960529 |
| 105 | MP0001661_extended_life_span | 0.97515728 |
| 106 | MP0004484_altered_response_of | 0.97288307 |
| 107 | MP0003879_abnormal_hair_cell | 0.97239734 |
| 108 | MP0008438_abnormal_cutaneous_collagen | 0.96727133 |
| 109 | MP0001835_abnormal_antigen_presentation | 0.95755060 |
| 110 | MP0003633_abnormal_nervous_system | 0.94928372 |
| 111 | MP0010234_abnormal_vibrissa_follicle | 0.94728536 |
| 112 | MP0008569_lethality_at_weaning | 0.93612145 |
| 113 | MP0004947_skin_inflammation | 0.93238878 |
| 114 | MP0001501_abnormal_sleep_pattern | 0.90676851 |
| 115 | MP0005375_adipose_tissue_phenotype | 0.90277910 |
| 116 | MP0003329_amyloid_beta_deposits | 0.89897115 |
| 117 | MP0000249_abnormal_blood_vessel | 0.87794797 |
| 118 | MP0000604_amyloidosis | 0.87699111 |
| 119 | MP0002572_abnormal_emotion/affect_behav | 0.87176228 |
| 120 | MP0005076_abnormal_cell_differentiation | 0.86738789 |
| 121 | MP0000013_abnormal_adipose_tissue | 0.85928788 |
| 122 | MP0005671_abnormal_response_to | 0.85530867 |
| 123 | MP0005330_cardiomyopathy | 0.85174038 |
| 124 | MP0001819_abnormal_immune_cell | 0.84748573 |
| 125 | MP0005501_abnormal_skin_physiology | 0.84052968 |
| 126 | MP0001873_stomach_inflammation | 0.82954410 |
| 127 | MP0000920_abnormal_myelination | 0.82827293 |
| 128 | MP0003634_abnormal_glial_cell | 0.82820098 |
| 129 | MP0002420_abnormal_adaptive_immunity | 0.82523490 |
| 130 | MP0002108_abnormal_muscle_morphology | 0.82335213 |
| 131 | MP0002098_abnormal_vibrissa_morphology | 0.80828733 |
| 132 | MP0009931_abnormal_skin_appearance | 0.80306891 |
| 133 | MP0004142_abnormal_muscle_tone | 0.80272444 |
| 134 | MP0004272_abnormal_basement_membrane | 0.80206609 |
| 135 | MP0000462_abnormal_digestive_system | 0.79705869 |
| 136 | MP0001879_abnormal_lymphatic_vessel | 0.79620353 |
| 137 | MP0010630_abnormal_cardiac_muscle | 0.79487249 |
| 138 | MP0000685_abnormal_immune_system | 0.79314782 |
| 139 | MP0000678_abnormal_parathyroid_gland | 0.79175644 |
| 140 | MP0002896_abnormal_bone_mineralization | 0.78969332 |
| 141 | MP0000955_abnormal_spinal_cord | 0.78890946 |
| 142 | MP0002272_abnormal_nervous_system | 0.78799476 |
| 143 | MP0004811_abnormal_neuron_physiology | 0.78718687 |
| 144 | MP0003448_altered_tumor_morphology | 0.77948135 |
| 145 | MP0000733_abnormal_muscle_development | 0.76524219 |
| 146 | MP0001727_abnormal_embryo_implantation | 0.76410462 |
| 147 | MP0005620_abnormal_muscle_contractility | 0.75673812 |
| 148 | MP0000427_abnormal_hair_cycle | 0.75405663 |
| 149 | MP0002405_respiratory_system_inflammati | 0.74197637 |
| 150 | MP0010307_abnormal_tumor_latency | 0.74170568 |
| 151 | MP0002972_abnormal_cardiac_muscle | 0.72880777 |
| 152 | MP0000343_altered_response_to | 0.72516224 |
| 153 | MP0010771_integument_phenotype | 0.72476136 |
| 154 | MP0008775_abnormal_heart_ventricle | 0.72236207 |
| 155 | MP0002254_reproductive_system_inflammat | 0.71796890 |
| 156 | MP0005257_abnormal_intraocular_pressure | 0.71030060 |
| 157 | MP0003690_abnormal_glial_cell | 0.70811135 |
| 158 | MP0001851_eye_inflammation | 0.70707727 |
| 159 | MP0008874_decreased_physiological_sensi | 0.69579684 |
| 160 | MP0004215_abnormal_myocardial_fiber | 0.68763146 |
| 161 | MP0002837_dystrophic_cardiac_calcinosis | 0.65187177 |
| 162 | MP0000003_abnormal_adipose_tissue | 0.64580137 |
| 163 | MP0000767_abnormal_smooth_muscle | 0.62739050 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Upper limb muscle weakness (HP:0003484) | 5.79011371 |
| 2 | Ulnar claw (HP:0001178) | 5.62230877 |
| 3 | Obstructive sleep apnea (HP:0002870) | 4.46706101 |
| 4 | Lower limb amyotrophy (HP:0007210) | 4.28705334 |
| 5 | Segmental peripheral demyelination/remyelination (HP:0003481) | 4.17256471 |
| 6 | Distal lower limb amyotrophy (HP:0008944) | 3.94131886 |
| 7 | Cervical subluxation (HP:0003308) | 3.85315572 |
| 8 | Onion bulb formation (HP:0003383) | 3.54692130 |
| 9 | Termporal pattern (HP:0011008) | 3.54286216 |
| 10 | Insidious onset (HP:0003587) | 3.54286216 |
| 11 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.46379258 |
| 12 | Thin bony cortex (HP:0002753) | 3.39526222 |
| 13 | Increased CSF protein (HP:0002922) | 3.38435249 |
| 14 | Broad face (HP:0000283) | 3.33431483 |
| 15 | Hyporeflexia of lower limbs (HP:0002600) | 3.27350885 |
| 16 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 3.22873052 |
| 17 | Difficulty running (HP:0009046) | 3.21705018 |
| 18 | Abnormality of the parathyroid morphology (HP:0011766) | 3.21036603 |
| 19 | Decreased motor nerve conduction velocity (HP:0003431) | 3.01868112 |
| 20 | Febrile seizures (HP:0002373) | 3.01861444 |
| 21 | Muscle fiber splitting (HP:0003555) | 2.96493943 |
| 22 | Dysostosis multiplex (HP:0000943) | 2.90499727 |
| 23 | Difficulty climbing stairs (HP:0003551) | 2.89371360 |
| 24 | Neurofibrillary tangles (HP:0002185) | 2.85896524 |
| 25 | Impaired proprioception (HP:0010831) | 2.83625717 |
| 26 | Distal lower limb muscle weakness (HP:0009053) | 2.82090037 |
| 27 | Chromsome breakage (HP:0040012) | 2.80173376 |
| 28 | Foot dorsiflexor weakness (HP:0009027) | 2.75807603 |
| 29 | Peripheral demyelination (HP:0011096) | 2.73487556 |
| 30 | Flat acetabular roof (HP:0003180) | 2.71806743 |
| 31 | Ankle clonus (HP:0011448) | 2.69137314 |
| 32 | Hammertoe (HP:0001765) | 2.64565094 |
| 33 | Action tremor (HP:0002345) | 2.63935965 |
| 34 | Steppage gait (HP:0003376) | 2.61847067 |
| 35 | Abnormality of nail color (HP:0100643) | 2.59127778 |
| 36 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.53437094 |
| 37 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.53437094 |
| 38 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.53437094 |
| 39 | Mucopolysacchariduria (HP:0008155) | 2.51480811 |
| 40 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.51480811 |
| 41 | Malnutrition (HP:0004395) | 2.46738673 |
| 42 | Increased connective tissue (HP:0009025) | 2.45861028 |
| 43 | Bundle branch block (HP:0011710) | 2.45705339 |
| 44 | Abnormality of the foot musculature (HP:0001436) | 2.44645462 |
| 45 | Urethral obstruction (HP:0000796) | 2.44241635 |
| 46 | Joint stiffness (HP:0001387) | 2.36787951 |
| 47 | Nuclear cataract (HP:0100018) | 2.34959738 |
| 48 | Fragile skin (HP:0001030) | 2.31549390 |
| 49 | Cerebral aneurysm (HP:0004944) | 2.29936691 |
| 50 | Focal segmental glomerulosclerosis (HP:0000097) | 2.29292958 |
| 51 | Mesangial abnormality (HP:0001966) | 2.28466134 |
| 52 | Plantar hyperkeratosis (HP:0007556) | 2.23959206 |
| 53 | Cerebral inclusion bodies (HP:0100314) | 2.22128712 |
| 54 | Mediastinal lymphadenopathy (HP:0100721) | 2.21562520 |
| 55 | Rapidly progressive (HP:0003678) | 2.20977005 |
| 56 | Exercise-induced myalgia (HP:0003738) | 2.19654958 |
| 57 | Focal seizures (HP:0007359) | 2.18954612 |
| 58 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.13818049 |
| 59 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.13818049 |
| 60 | Abnormality of glycolipid metabolism (HP:0010969) | 2.13818049 |
| 61 | Myotonia (HP:0002486) | 2.12955567 |
| 62 | Prostate neoplasm (HP:0100787) | 2.12911705 |
| 63 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.12598949 |
| 64 | Colitis (HP:0002583) | 2.12568538 |
| 65 | Distal sensory impairment (HP:0002936) | 2.12530307 |
| 66 | Eczematoid dermatitis (HP:0000976) | 2.11542902 |
| 67 | Increased cerebral lipofuscin (HP:0011813) | 2.11094112 |
| 68 | Asymmetric septal hypertrophy (HP:0001670) | 2.10695209 |
| 69 | Exotropia (HP:0000577) | 2.10033494 |
| 70 | Disproportionate tall stature (HP:0001519) | 2.09391111 |
| 71 | Annular pancreas (HP:0001734) | 2.08406638 |
| 72 | Urinary urgency (HP:0000012) | 2.07993810 |
| 73 | Shallow orbits (HP:0000586) | 2.07352478 |
| 74 | Atrophic scars (HP:0001075) | 2.05613627 |
| 75 | Right ventricular cardiomyopathy (HP:0011663) | 2.05531824 |
| 76 | Progressive sensorineural hearing impairment (HP:0000408) | 2.05095168 |
| 77 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.04355711 |
| 78 | Onycholysis (HP:0001806) | 2.03301423 |
| 79 | Hemorrhage of the eye (HP:0011885) | 2.03100801 |
| 80 | Stage 5 chronic kidney disease (HP:0003774) | 2.00794779 |
| 81 | Pustule (HP:0200039) | 1.99913209 |
| 82 | Epiphyseal dysplasia (HP:0002656) | 1.99532906 |
| 83 | Nephritis (HP:0000123) | 1.98434614 |
| 84 | Neonatal respiratory distress (HP:0002643) | 1.97179675 |
| 85 | Frequent falls (HP:0002359) | 1.97019050 |
| 86 | Abnormality of the fingertips (HP:0001211) | 1.96733463 |
| 87 | Delayed epiphyseal ossification (HP:0002663) | 1.96417036 |
| 88 | Abnormal vertebral ossification (HP:0100569) | 1.96140724 |
| 89 | Focal motor seizures (HP:0011153) | 1.95863060 |
| 90 | Submucous cleft hard palate (HP:0000176) | 1.94623376 |
| 91 | Alopecia of scalp (HP:0002293) | 1.94521443 |
| 92 | Fragile nails (HP:0001808) | 1.94384605 |
| 93 | Nail dystrophy (HP:0008404) | 1.94321755 |
| 94 | J-shaped sella turcica (HP:0002680) | 1.93425493 |
| 95 | Aneurysm (HP:0002617) | 1.91451618 |
| 96 | Hypoplastic ischia (HP:0003175) | 1.91168410 |
| 97 | Spontaneous hematomas (HP:0007420) | 1.90921202 |
| 98 | Thoracic kyphosis (HP:0002942) | 1.90107987 |
| 99 | Enlarged epiphyses (HP:0010580) | 1.89904281 |
| 100 | Protuberant abdomen (HP:0001538) | 1.87908168 |
| 101 | Stridor (HP:0010307) | 1.87100455 |
| 102 | Limited hip movement (HP:0008800) | 1.85434755 |
| 103 | Progressive hearing impairment (HP:0001730) | 1.83086953 |
| 104 | Mask-like facies (HP:0000298) | 1.82964403 |
| 105 | Metaphyseal cupping (HP:0003021) | 1.82910827 |
| 106 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.82306604 |
| 107 | Thin ribs (HP:0000883) | 1.81729697 |
| 108 | Tetany (HP:0001281) | 1.81267758 |
| 109 | Sudden death (HP:0001699) | 1.80810241 |
| 110 | Abnormality of macrophages (HP:0004311) | 1.80808227 |
| 111 | Pili torti (HP:0003777) | 1.80280004 |
| 112 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.79786939 |
| 113 | Loss of speech (HP:0002371) | 1.79475647 |
| 114 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.79087938 |
| 115 | Abnormality of vision evoked potentials (HP:0000649) | 1.78604276 |
| 116 | Vertebral clefting (HP:0008428) | 1.78316147 |
| 117 | Supranuclear gaze palsy (HP:0000605) | 1.78241868 |
| 118 | Neuronal loss in central nervous system (HP:0002529) | 1.77407801 |
| 119 | Glomerulonephritis (HP:0000099) | 1.77302398 |
| 120 | Stomatitis (HP:0010280) | 1.76101426 |
| 121 | Increased IgE level (HP:0003212) | 1.75471299 |
| 122 | Hyperacusis (HP:0010780) | 1.75356474 |
| 123 | Mitral valve prolapse (HP:0001634) | 1.75119768 |
| 124 | Abnormality of the thoracic spine (HP:0100711) | 1.75073740 |
| 125 | Vitreoretinal degeneration (HP:0000655) | 1.75004416 |
| 126 | Abnormal blistering of the skin (HP:0008066) | 1.74928115 |
| 127 | Abnormality of the peritoneum (HP:0002585) | 1.74614803 |
| 128 | Interstitial pulmonary disease (HP:0006530) | 1.73986502 |
| 129 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.73983219 |
| 130 | Hand muscle atrophy (HP:0009130) | 1.73825781 |
| 131 | Systemic lupus erythematosus (HP:0002725) | 1.73682135 |
| 132 | Lower limb muscle weakness (HP:0007340) | 1.73393016 |
| 133 | Ulnar bowing (HP:0003031) | 1.73037946 |
| 134 | Premature rupture of membranes (HP:0001788) | 1.72640138 |
| 135 | Lip pit (HP:0100267) | 1.72417380 |
| 136 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.71672767 |
| 137 | Progressive cerebellar ataxia (HP:0002073) | 1.70204086 |
| 138 | Increased variability in muscle fiber diameter (HP:0003557) | 1.70040175 |
| 139 | Milia (HP:0001056) | 1.69533800 |
| 140 | Hemiplegia (HP:0002301) | 1.69417614 |
| 141 | Hypoplasia of dental enamel (HP:0006297) | 1.69234998 |
| 142 | Abnormality of the neuromuscular junction (HP:0003398) | 1.68693718 |
| 143 | Fatigable weakness (HP:0003473) | 1.68693718 |
| 144 | Distal arthrogryposis (HP:0005684) | 1.68605882 |
| 145 | Resting tremor (HP:0002322) | 1.68311627 |
| 146 | Abnormality of the ischium (HP:0003174) | 1.68074370 |
| 147 | Polygenic inheritance (HP:0010982) | 1.64969800 |
| 148 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.64712685 |
| 149 | Flat capital femoral epiphysis (HP:0003370) | 1.64620906 |
| 150 | Hematochezia (HP:0002573) | 1.64139041 |
| 151 | Dislocated radial head (HP:0003083) | 1.63595470 |
| 152 | Lymphangioma (HP:0100764) | 1.63411801 |
| 153 | Protrusio acetabuli (HP:0003179) | 1.63137491 |
| 154 | Global brain atrophy (HP:0002283) | 1.62773502 |
| 155 | Long toe (HP:0010511) | 1.62114140 |
| 156 | Postural tremor (HP:0002174) | 1.62073320 |
| 157 | Upper limb amyotrophy (HP:0009129) | 1.61614324 |
| 158 | Distal upper limb amyotrophy (HP:0007149) | 1.61614324 |
| 159 | Axonal loss (HP:0003447) | 1.61477173 |
| 160 | Flattened epiphyses (HP:0003071) | 1.61330355 |
| 161 | Abnormality of the radial head (HP:0003995) | 1.60949930 |
| 162 | Chin dimple (HP:0010751) | 1.60861610 |
| 163 | Syncope (HP:0001279) | 1.60660623 |
| 164 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.60480633 |
| 165 | Elfin facies (HP:0004428) | 1.59931238 |
| 166 | Autoimmune thrombocytopenia (HP:0001973) | 1.59239069 |
| 167 | Esophageal varix (HP:0002040) | 1.59114088 |
| 168 | Gingivitis (HP:0000230) | 1.58925239 |
| 169 | Hypoplasia of the odontoid process (HP:0003311) | 1.58752144 |
| 170 | EMG: neuropathic changes (HP:0003445) | 1.58398355 |
| 171 | Orchitis (HP:0100796) | 1.58130946 |
| 172 | Postural instability (HP:0002172) | 1.58079367 |
| 173 | Thick nail (HP:0001805) | 1.57830165 |
| 174 | Glomerulosclerosis (HP:0000096) | 1.56007089 |
| 175 | Embryonal renal neoplasm (HP:0011794) | 1.55933603 |
| 176 | Persistence of primary teeth (HP:0006335) | 1.55848190 |
| 177 | Slow saccadic eye movements (HP:0000514) | 1.54332359 |
| 178 | Bradycardia (HP:0001662) | 1.53726729 |
| 179 | Atonic seizures (HP:0010819) | 1.53696296 |
| 180 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.53658157 |
| 181 | Abnormality of the calf musculature (HP:0001430) | 1.52338495 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 3.87475763 |
| 2 | NTRK3 | 3.08358605 |
| 3 | GRK1 | 2.81780851 |
| 4 | MAP3K13 | 2.75583859 |
| 5 | CAMK1D | 2.63276805 |
| 6 | SIK1 | 2.60306044 |
| 7 | RIPK4 | 2.55094431 |
| 8 | CAMK1G | 2.53978782 |
| 9 | CASK | 2.48968791 |
| 10 | TIE1 | 2.38845522 |
| 11 | DDR2 | 2.22035052 |
| 12 | PRPF4B | 2.15663703 |
| 13 | MST1R | 2.09496996 |
| 14 | ERN1 | 2.07348466 |
| 15 | MAPK15 | 1.99693448 |
| 16 | TTN | 1.96202817 |
| 17 | LMTK2 | 1.84935183 |
| 18 | MAP3K14 | 1.77151548 |
| 19 | EPHA2 | 1.75419287 |
| 20 | TNK2 | 1.74950553 |
| 21 | MAP4K1 | 1.68387545 |
| 22 | TRIB3 | 1.63993267 |
| 23 | PTK2B | 1.61581157 |
| 24 | DAPK2 | 1.57186888 |
| 25 | JAK1 | 1.55529266 |
| 26 | SIK2 | 1.52767583 |
| 27 | OBSCN | 1.51904164 |
| 28 | MAP3K4 | 1.48764184 |
| 29 | PHKG2 | 1.46841321 |
| 30 | PHKG1 | 1.46841321 |
| 31 | RET | 1.44322014 |
| 32 | CDK12 | 1.41900358 |
| 33 | TAOK3 | 1.40739803 |
| 34 | ZAP70 | 1.37523834 |
| 35 | TBK1 | 1.30903509 |
| 36 | WNK1 | 1.30155720 |
| 37 | EPHB1 | 1.29850443 |
| 38 | SIK3 | 1.29138651 |
| 39 | PAK6 | 1.27055394 |
| 40 | CSK | 1.25674816 |
| 41 | PKN2 | 1.25107778 |
| 42 | PRKD2 | 1.22771705 |
| 43 | ARAF | 1.21965270 |
| 44 | ICK | 1.20219097 |
| 45 | FGFR4 | 1.20184712 |
| 46 | FGR | 1.18084503 |
| 47 | CDK19 | 1.17812894 |
| 48 | TGFBR2 | 1.17243566 |
| 49 | MAP2K3 | 1.14553171 |
| 50 | SMG1 | 1.14351231 |
| 51 | INSRR | 1.13784886 |
| 52 | RIPK1 | 1.11046751 |
| 53 | MAP3K7 | 1.09479093 |
| 54 | CDC42BPA | 1.09234407 |
| 55 | FER | 1.08400794 |
| 56 | DMPK | 1.05375222 |
| 57 | KSR2 | 1.04681769 |
| 58 | MAP3K3 | 1.04212422 |
| 59 | PDK1 | 1.02029001 |
| 60 | MAP3K11 | 1.00363571 |
| 61 | PTK6 | 0.99853031 |
| 62 | IRAK3 | 0.99766932 |
| 63 | FES | 0.99707924 |
| 64 | KDR | 0.99049489 |
| 65 | PDGFRA | 0.98077267 |
| 66 | NME2 | 0.97361416 |
| 67 | TYK2 | 0.97066018 |
| 68 | MET | 0.95840581 |
| 69 | PDPK1 | 0.93146591 |
| 70 | EPHA3 | 0.92712638 |
| 71 | PTK2 | 0.86897539 |
| 72 | JAK3 | 0.85899334 |
| 73 | TAOK1 | 0.85006120 |
| 74 | MAP2K4 | 0.82502227 |
| 75 | IKBKE | 0.82172141 |
| 76 | SGK1 | 0.82079755 |
| 77 | MAP3K2 | 0.81541612 |
| 78 | EEF2K | 0.80914545 |
| 79 | TYRO3 | 0.80604316 |
| 80 | ERBB2 | 0.79642734 |
| 81 | PLK2 | 0.79631460 |
| 82 | MAP2K6 | 0.77966042 |
| 83 | CHUK | 0.75724168 |
| 84 | PRKD3 | 0.74964740 |
| 85 | MAPK7 | 0.74815383 |
| 86 | CDK5 | 0.73868312 |
| 87 | SGK2 | 0.73716814 |
| 88 | MAPK12 | 0.73588104 |
| 89 | PDK3 | 0.72907633 |
| 90 | PDK4 | 0.72907633 |
| 91 | RPS6KL1 | 0.72757506 |
| 92 | RPS6KC1 | 0.72757506 |
| 93 | HIPK2 | 0.71638508 |
| 94 | NTRK1 | 0.70792984 |
| 95 | SGK3 | 0.68147675 |
| 96 | MINK1 | 0.66997942 |
| 97 | TRPM7 | 0.66574191 |
| 98 | WNK4 | 0.66506944 |
| 99 | BMX | 0.66285967 |
| 100 | CSF1R | 0.66285156 |
| 101 | TAOK2 | 0.66204475 |
| 102 | MAPK10 | 0.65821981 |
| 103 | OXSR1 | 0.65131906 |
| 104 | CAMKK2 | 0.63398319 |
| 105 | MARK2 | 0.61781392 |
| 106 | PKN1 | 0.61132886 |
| 107 | HCK | 0.60886150 |
| 108 | MAP3K6 | 0.60846682 |
| 109 | RPS6KA6 | 0.60803209 |
| 110 | IKBKB | 0.59836177 |
| 111 | ITK | 0.59406884 |
| 112 | PAK2 | 0.59266787 |
| 113 | STK11 | 0.58885899 |
| 114 | SGK223 | 0.58885723 |
| 115 | SGK494 | 0.58885723 |
| 116 | MOS | 0.58404882 |
| 117 | PAK4 | 0.58092958 |
| 118 | PIK3CA | 0.58043708 |
| 119 | MAP3K1 | 0.57512363 |
| 120 | JAK2 | 0.56102682 |
| 121 | PRKCH | 0.55694939 |
| 122 | BTK | 0.55552296 |
| 123 | MAP2K7 | 0.55395710 |
| 124 | CAMKK1 | 0.54955176 |
| 125 | EPHB2 | 0.54921365 |
| 126 | PDK2 | 0.54227789 |
| 127 | ROCK1 | 0.53754133 |
| 128 | RPS6KA2 | 0.53706233 |
| 129 | PRKAA2 | 0.53034265 |
| 130 | STK38 | 0.52367576 |
| 131 | PRKCE | 0.51833039 |
| 132 | PDGFRB | 0.51021327 |
| 133 | MTOR | 0.50172700 |
| 134 | BRD4 | 0.49269642 |
| 135 | MATK | 0.48810493 |
| 136 | PIM2 | 0.47377837 |
| 137 | FYN | 0.46827393 |
| 138 | LCK | 0.46777705 |
| 139 | PIK3CG | 0.46306922 |
| 140 | INSR | 0.45796294 |
| 141 | DAPK1 | 0.44925275 |
| 142 | LATS2 | 0.44482057 |
| 143 | BLK | 0.42836831 |
| 144 | PRKD1 | 0.42143032 |
| 145 | MUSK | 0.41875396 |
| 146 | KIT | 0.40472028 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 2.46034175 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.10822021 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.84636548 |
| 4 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.79800273 |
| 5 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.79340732 |
| 6 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.73590447 |
| 7 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.53125017 |
| 8 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.50557968 |
| 9 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.49344554 |
| 10 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.48177549 |
| 11 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.47727308 |
| 12 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.44626851 |
| 13 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.41722046 |
| 14 | Olfactory transduction_Homo sapiens_hsa04740 | 1.40006262 |
| 15 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.34950116 |
| 16 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.34607367 |
| 17 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.33706489 |
| 18 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.29104223 |
| 19 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.29021632 |
| 20 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.28288485 |
| 21 | Malaria_Homo sapiens_hsa05144 | 1.28217496 |
| 22 | Renin secretion_Homo sapiens_hsa04924 | 1.24975234 |
| 23 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.24859172 |
| 24 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.23714939 |
| 25 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.22029422 |
| 26 | Salivary secretion_Homo sapiens_hsa04970 | 1.20461764 |
| 27 | Prion diseases_Homo sapiens_hsa05020 | 1.20139692 |
| 28 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.18048975 |
| 29 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.17805193 |
| 30 | Morphine addiction_Homo sapiens_hsa05032 | 1.17792197 |
| 31 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.15361334 |
| 32 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.14932268 |
| 33 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.13853664 |
| 34 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.13454586 |
| 35 | Focal adhesion_Homo sapiens_hsa04510 | 1.13299068 |
| 36 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.12318561 |
| 37 | Circadian entrainment_Homo sapiens_hsa04713 | 1.10269305 |
| 38 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.09365327 |
| 39 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.08565296 |
| 40 | Insulin secretion_Homo sapiens_hsa04911 | 1.07198151 |
| 41 | Axon guidance_Homo sapiens_hsa04360 | 1.06560235 |
| 42 | Glioma_Homo sapiens_hsa05214 | 1.05662308 |
| 43 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.05551028 |
| 44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.04920363 |
| 45 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.04625085 |
| 46 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.04417987 |
| 47 | Bladder cancer_Homo sapiens_hsa05219 | 1.04255489 |
| 48 | Hepatitis C_Homo sapiens_hsa05160 | 1.02504330 |
| 49 | Amoebiasis_Homo sapiens_hsa05146 | 1.02418484 |
| 50 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.01780233 |
| 51 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.00735816 |
| 52 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.99614758 |
| 53 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.98989103 |
| 54 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.98851689 |
| 55 | Long-term potentiation_Homo sapiens_hsa04720 | 0.98638607 |
| 56 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.97869040 |
| 57 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.97859879 |
| 58 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.97135891 |
| 59 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.96279237 |
| 60 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.95772127 |
| 61 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.93842138 |
| 62 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.93739714 |
| 63 | Insulin resistance_Homo sapiens_hsa04931 | 0.93350204 |
| 64 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.92175843 |
| 65 | Nicotine addiction_Homo sapiens_hsa05033 | 0.91947853 |
| 66 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.91250696 |
| 67 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.88928401 |
| 68 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.87915526 |
| 69 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.86381438 |
| 70 | Lysosome_Homo sapiens_hsa04142 | 0.86195796 |
| 71 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.85775721 |
| 72 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.85449680 |
| 73 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.84999486 |
| 74 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.84559819 |
| 75 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.83887161 |
| 76 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.83801826 |
| 77 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.83792906 |
| 78 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.83483570 |
| 79 | Tuberculosis_Homo sapiens_hsa05152 | 0.82686219 |
| 80 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.81820198 |
| 81 | Platelet activation_Homo sapiens_hsa04611 | 0.81680767 |
| 82 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.81503854 |
| 83 | Taste transduction_Homo sapiens_hsa04742 | 0.81180817 |
| 84 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.80015251 |
| 85 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.79914005 |
| 86 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.79501937 |
| 87 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.78397185 |
| 88 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.78179121 |
| 89 | Melanoma_Homo sapiens_hsa05218 | 0.77850354 |
| 90 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.77756101 |
| 91 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.77664916 |
| 92 | Endometrial cancer_Homo sapiens_hsa05213 | 0.77481723 |
| 93 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.77313203 |
| 94 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.77051842 |
| 95 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.76235282 |
| 96 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.76129021 |
| 97 | Phagosome_Homo sapiens_hsa04145 | 0.76073453 |
| 98 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.75753804 |
| 99 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.73567241 |
| 100 | Pertussis_Homo sapiens_hsa05133 | 0.71537895 |
| 101 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.70890349 |
| 102 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.70505992 |
| 103 | Salmonella infection_Homo sapiens_hsa05132 | 0.70481981 |
| 104 | Phototransduction_Homo sapiens_hsa04744 | 0.70372069 |
| 105 | Endocytosis_Homo sapiens_hsa04144 | 0.69889978 |
| 106 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.69809426 |
| 107 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.69611442 |
| 108 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.69518143 |
| 109 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.68785299 |
| 110 | ABC transporters_Homo sapiens_hsa02010 | 0.68719817 |
| 111 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.68573433 |
| 112 | Measles_Homo sapiens_hsa05162 | 0.68389613 |
| 113 | Hepatitis B_Homo sapiens_hsa05161 | 0.68145178 |
| 114 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.67515112 |
| 115 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.66427778 |
| 116 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.66203909 |
| 117 | Lysine degradation_Homo sapiens_hsa00310 | 0.66016440 |
| 118 | Apoptosis_Homo sapiens_hsa04210 | 0.65397029 |
| 119 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.65175909 |
| 120 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65062875 |
| 121 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.64706288 |
| 122 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.64600044 |
| 123 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.64545075 |
| 124 | Leishmaniasis_Homo sapiens_hsa05140 | 0.64279517 |
| 125 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.63425804 |
| 126 | Influenza A_Homo sapiens_hsa05164 | 0.63273228 |
| 127 | Allograft rejection_Homo sapiens_hsa05330 | 0.63048547 |
| 128 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.62728027 |
| 129 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.60895945 |
| 130 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.58868019 |
| 131 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.55975111 |
| 132 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55552997 |

